JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egan, T. D.
Right arrow Articles by Pace, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egan, T. D.
Right arrow Articles by Pace, N. L.
Related Collections
Right arrow Pharmacology

Anesth Analg 2003;97:72-79
© 2003 International Anesthesia Research Society


ANESTHETIC PHARMACOLOGY

The Pharmacokinetics and Pharmacodynamics of Propofol in a Modified Cyclodextrin Formulation (Captisol®) Versus Propofol in a Lipid Formulation (Diprivan®): An Electroencephalographic and Hemodynamic Study in a Porcine Model

Talmage D. Egan, MD*, Steven E. Kern, PhD{dagger}, Kenward B. Johnson, MD*, and Nathan L. Pace, MD MStat*

*Department of Anesthesiology, University of Utah School of Medicine; and {dagger}Department of Pharmaceutics and Anesthesiology, University of Utah Schools of Pharmacy and Medicine, Salt Lake City, Utah

Address correspondence and reprint requests to Talmage D. Egan, MD, Department of Anesthesiology, University of Utah Health Sciences Center, Room 3C444, 30 N. 1900 E., Salt Lake City, UT 84132-2304. Address e-mail to talmage.egan{at}hsc.utah.edu

The currently marketed propofol formulation has a number of undesirable properties that are in part a function of the lipid emulsion formulation, including pain on injection, serious allergic reactions, and the support of microbial growth. A modified cyclodextrin-based formulation of propofol (sulfobutyl ether-ß-cyclodextrin) has been developed that may mitigate some of these formulation-dependent problems. However, reformulation may alter propofol’s pharmacologic behavior. Our aim in this study was to compare the pharmacokinetics and pharmacodynamics of propofol in the currently marketed lipid-based formulation with those of the novel cyclodextrin formulation. We hypothesized that the pharmacokinetics and pharmacodynamics of the propofol in cyclodextrin would be substantially similar to those of the propofol in lipid. Thirty-two isoflurane-anesthetized animals were instrumented with pulmonary artery, arterial, and IV catheters and were randomly assigned to receive either propofol in lipid or propofol in cyclodextrin by continuous infusion. Arterial blood samples for propofol assay were collected. The processed electroencephalogram, heart rate, mean arterial blood pressure, and cardiac output were measured continuously. The propofol formulations were compared by using model-independent analysis techniques. Combined kinetic/dynamic models were also constructed for simulation purposes. There were no significant differences in the pharmacokinetics or pharmacodynamics of the two propofol formulations. The simulations based on the combined pharmacokinetic/pharmacodynamic models confirmed the substantial similarity of the two formulations. The hypothesis that the propofol-in-cyclodextrin formulation would exhibit pharmacokinetic and pharmacodynamic behavior that was substantially similar to the propofol-in-lipid formulation was confirmed.

IMPLICATIONS: A modified cyclodextrin-based formulation of propofol has been developed that may mitigate some of the problems associated with propofol in lipid emulsion. However, reformulation of propofol may change its clinical characteristics. This study in a pig model showed that the novel propofol formulation was substantially similar to the lipid emulsion propofol formulation.




This article has been cited by other articles:


Home page
J Clin PharmacolHome page
D. J. Cushing, M. P. Adams, W. D. Cooper, P. R. Kowey, and R. J. Lipicky
Bioequivalence of 2 Intravenous Amiodarone Formulations in Healthy Participants
J. Clin. Pharmacol., April 1, 2009; 49(4): 407 - 415.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
F. Ravenelle, P. Vachon, A. E. Rigby-Jones, J. R. Sneyd, D. Le Garrec, S. Gori, D. Lessard, and D. C. Smith
Anaesthetic effects of propofol polymeric micelle: a novel water soluble propofol formulation
Br. J. Anaesth., August 1, 2008; 101(2): 186 - 193.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. G. Bovill
Anesthetic Pharmacology: Reflections of a Section Editor
Anesth. Analg., November 1, 2007; 105(5): 1186 - 1190.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Naguib, A. F. Kopman, and J. E. Ensor
Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis
Br. J. Anaesth., March 1, 2007; 98(3): 302 - 316.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Naguib
Sugammadex: Another Milestone in Clinical Neuromuscular Pharmacology
Anesth. Analg., March 1, 2007; 104(3): 575 - 581.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J. M. Hunter and E. A. Flockton
The doughnut and the hole: a new pharmacological concept for anaesthetists.
Br. J. Anaesth., August 1, 2006; 97(2): 123 - 126.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. Fechner, H. Ihmsen, C. Schiessl, C. Jeleazcov, J. J. Vornov, H. Schwilden, and J. Schuttler
Sedation with GPI 15715, a Water-Soluble Prodrug of Propofol, Using Target-Controlled Infusion in Volunteers
Anesth. Analg., March 1, 2005; 100(3): 701 - 706.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J. R. Sneyd
Recent advances in intravenous anaesthesia
Br. J. Anaesth., November 1, 2004; 93(5): 725 - 736.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2003 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2003 by the International Anesthesia Research Society.